Search Count: 5
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2020-03-11 Classification: IMMUNE SYSTEM Ligands: R6D |
 |
N-Terminal Bromodomain Of Human Brd2 With N-((4-(3-(N-Cyclopentylsulfamoyl)-4-Methylphenyl)-3-Methylisoxazol-5-Yl)Methyl)Acetamide Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2019-01-23 Classification: transcription/transcription inhibitor Ligands: JWA |
 |
N-Terminal Bromodomain Of Human Brd2 In Complex With 4,4'-(Quinoline-5,7-Diyl)Bis(3,5-Dimethylisoxazole) Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2019-01-23 Classification: transcription/transcription inhibitor Ligands: JWD, SO4 |
 |
N-Terminal Bromodomain Of Human Brd2 In Complex With N-Cyclopentyl-7-(3,5-Dimethylisoxazol-4-Yl)Quinoline-5-Sulfonamide Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2019-01-23 Classification: transcription/transcription inhibitor Ligands: JVY |
 |
C-Terminal Bromodomain Of Human Brd2 In Complex With 4-(2-Cyclopropyl-7-(6-Methylquinolin-5-Yl)-1H-Benzo[D]Imidazol-5-Yl)-3,5-Dimethylisoxazole Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.27 Å Release Date: 2019-01-23 Classification: transcription/transcription inhibitor Ligands: JW4, GOL |